Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Down 8.6% in January

Astrana Health, Inc. (NASDAQ:ASTH) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 1,490,000 shares, a decrease of 8.6% from the December 31st total of 1,630,000 shares. Based on an average daily trading volume, of 303,600 shares, the days-to-cover ratio is presently 4.9 days. Currently, 4.2% of the company’s shares are sold short.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Handelsbanken Fonder AB grew its stake in shares of Astrana Health by 4.7% during the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock worth $281,000 after acquiring an additional 400 shares during the last quarter. GAMMA Investing LLC acquired a new stake in Astrana Health in the 3rd quarter worth approximately $34,000. Nisa Investment Advisors LLC purchased a new stake in Astrana Health during the 3rd quarter worth approximately $35,000. KBC Group NV purchased a new stake in Astrana Health during the 3rd quarter worth approximately $70,000. Finally, Quarry LP acquired a new position in Astrana Health during the 3rd quarter valued at approximately $77,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of research analyst reports. Robert W. Baird upped their target price on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Macquarie upgraded shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th. TD Cowen initiated coverage on Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective on the stock. Truist Financial cut their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research report on Monday, January 13th. Finally, KeyCorp assumed coverage on shares of Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $63.67.

Astrana Health Stock Up 0.2 %

Shares of ASTH traded up $0.09 during mid-day trading on Monday, hitting $36.96. The company’s stock had a trading volume of 100,769 shares, compared to its average volume of 379,222. The company’s 50-day moving average is $36.27 and its 200-day moving average is $46.31. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.08 billion, a price-to-earnings ratio of 28.37, a PEG ratio of 1.42 and a beta of 1.20. Astrana Health has a 52-week low of $29.08 and a 52-week high of $63.20.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. During the same period in the prior year, the firm posted $0.47 earnings per share. On average, equities research analysts forecast that Astrana Health will post 1.15 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.